Proteocyte has developed a test that can distinguishes between high risk precancerous oral lesions and those that pose low risk of developing into cancer.
Monthly Archives: November 2014
ChipCare’s integrated point-of-care diagnostic and patient management system leverages recent advances in microfluidic and biomarker technologies to provide cell surface and blood analyte tests. Designed for community-level health workers, the Flow-LM is coupled with a mobile app to provide job task and training support, and to gather patient data. Wireless communication allows centrally located clinicians to advise front-line health workers, improving health system efficiency, decreasing cost and ultimately saving lives. Cloud EMR data aggregation provides health system managers and researchers with the information they need to make evidence-based program, funding and policy decisions.
PPI received the honour for its successful commercialization strategy, securing licensing and co-development agreements with collaborators such as Bayer CropScience, Mahyco and Biocentury Transgene. In conjunction with its partners, PPI is opening new markets, creating and strengthening both new and established alliances, forming a solid technology and product matrix for global commercialization.
PPI was also a finalist in a second of thirteen total categories: Best R&D Pipeline.
Entries were judged by an independent panel consisting of senior experts worldwide.
Agrow is a leading industry provider of agricultural news, analysis and data services in crop protection and business intelligence world-wide and hosts leading industry awards for innovation and excellence each year.